pGEX6P1-mCherry-Nanobody (LaM-2) Citations (2)
Originally described in: Molecular basis of ciliary defects caused by compound heterozygous IFT144/WDR19 mutations found in cranioectodermal dysplasia.Ishida Y, Kobayashi T, Chiba S, Katoh Y, Nakayama K Hum Mol Genet. 2021 Apr 26;30(3-4):213-225. doi: 10.1093/hmg/ddab034. PubMed Journal
Articles Citing pGEX6P1-mCherry-Nanobody (LaM-2)
Articles |
---|
Solo regulates the localization and activity of PDZ-RhoGEF for actin cytoskeletal remodeling in response to substrate stiffness. Kunitomi A, Chiba S, Higashitani N, Higashitani A, Sato S, Mizuno K, Ohashi K. Mol Biol Cell. 2024 Jun 1;35(6):ar87. doi: 10.1091/mbc.E23-11-0421. Epub 2024 Apr 24. PubMed |
Engineering of CD63 Enables Selective Extracellular Vesicle Cargo Loading and Enhanced Payload Delivery. Obuchi W, Zargani-Piccardi A, Leandro K, Rufino-Ramos D, Di Lanni E, Frederick DM, Maalouf K, Nieland L, Xiao T, Repiton P, Vaine CA, Kleinstiver BP, Bragg DC, Lee H, Miller MA, Breakefield XO, Breyne K. J Extracell Vesicles. 2025 Jun;14(6):e70094. doi: 10.1002/jev2.70094. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.